3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Brain Neoplasms
7
Glioblastoma
6
Squamous Cell Carcinoma of Head and Neck
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Gliosarcoma
5
Polycythemia Vera
4
Meningioma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Neoplasms
3
Leukemia
3
Laryngeal Neoplasms
3
Glioma
3
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Myelodysplastic Syndromes
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Squamous Cell
2
Tongue Neoplasms
1
Thrombosis
1
Thrombocytosis
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Recurrence
1
Polycythemia
1
Papillomavirus Infections
1
Interventions
ruxolitinib
1
posaconazole
1
Stem Cell Transplantation
1
Low-Level Light Therapy
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bone Marrow Neoplasms
×
Hydroxyurea
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled